Amniotics Future Growth
Future criteria checks 3/6
Amniotics is forecast to grow earnings and revenue by 84.5% and 119.9% per annum respectively.
Key information
84.5%
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 38.9% |
Revenue growth rate | 119.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 26 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 108 | 82 | N/A | 28 | 1 |
12/31/2025 | N/A | -24 | N/A | -24 | 1 |
12/31/2024 | N/A | -24 | N/A | -24 | 1 |
12/31/2023 | N/A | -31 | -29 | -29 | N/A |
9/30/2023 | N/A | -35 | -39 | -36 | N/A |
6/30/2023 | N/A | -45 | -43 | -40 | N/A |
3/31/2023 | N/A | -49 | -16 | -13 | N/A |
12/31/2022 | N/A | -48 | -49 | -46 | N/A |
9/30/2022 | N/A | -51 | -46 | -44 | N/A |
6/30/2022 | N/A | -45 | 8 | 11 | N/A |
3/31/2022 | N/A | -52 | -50 | -49 | N/A |
12/31/2021 | N/A | -54 | -17 | -16 | N/A |
9/30/2021 | N/A | -54 | -53 | -51 | N/A |
6/30/2021 | N/A | -50 | -107 | -104 | N/A |
3/31/2021 | N/A | -38 | -41 | -35 | N/A |
12/31/2020 | N/A | -31 | -67 | -62 | N/A |
12/31/2019 | N/A | -10 | N/A | N/A | N/A |
12/31/2018 | 0 | -7 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMNI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: AMNI is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AMNI is expected to become profitable in the next 3 years.
Revenue vs Market: AMNI is forecast to have no revenue next year.
High Growth Revenue: AMNI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AMNI's Return on Equity is forecast to be high in 3 years time